Prolia (denosumab) stays active in your system for about six months after each injection, which is why doses are scheduled every six months. But its effects on your bones don’t end when the drug clears. After your last dose, the biological changes Prolia triggered can take 12 months or longer to fully reverse, and that reversal itself carries risks worth understanding.
How Prolia Works Between Injections
Each 60 mg injection of Prolia starts working fast. Within three days, it reduces a key marker of bone breakdown by roughly 85%, with maximum suppression hitting around the one-month mark. For the first one to three months after an injection, bone breakdown is suppressed so heavily that standard blood tests can’t even detect it in many patients.
That suppression doesn’t hold steady for the full six months, though. As drug levels in your blood naturally decline, bone breakdown gradually picks back up. By the time you’re due for your next injection, the suppression has weakened from its peak of 87% or greater down to somewhere between 45% and 80%. This is normal and expected. It’s also the reason your injections are spaced exactly six months apart: the drug is losing its grip, and the next dose resets the clock.
What Happens After You Stop
If you stop Prolia entirely, the drug clears from your system within roughly six months of your last injection. But your bones don’t simply return to their pre-treatment state. They overshoot. Markers of bone breakdown don’t just return to where they were before treatment. They rise 40% to 60% above your original baseline, meaning your bones temporarily break down faster than they did before you ever started Prolia. This rebound effect is the central concern with stopping the drug, and it takes about 12 months to settle back to normal levels.
That rebound translates to real bone loss. In one long-term study, patients who had gained 16.8% bone density in the lumbar spine over eight years of Prolia therapy lost 6.7% of it in just the first year after stopping. That’s a significant chunk of progress erased in a fraction of the time it took to build.
The Rebound Fracture Window
The most serious consequence of this rebound is an increased risk of vertebral fractures, sometimes multiple fractures at once. Australia’s Therapeutic Goods Administration has issued strengthened warnings about this, noting that new vertebral fractures have occurred as early as seven months after the last dose. That seven-month mark lines up with when the drug has largely cleared your system and the rebound in bone breakdown is accelerating.
Patients who already had vertebral fractures before or during treatment face the highest risk. For this reason, stopping Prolia is not something you do casually. The standard approach is to transition to a different osteoporosis medication, typically a bisphosphonate, to cushion the landing and prevent that rebound from causing damage. In one study where patients were switched to a bisphosphonate after 12 months of Prolia, some still lost bone density at the hip and femoral neck (7.6% and 21.7%, respectively), showing that even with a transition drug, not all of the gains are preserved.
Body Weight and Kidney Function Don’t Change the Timeline
Unlike many medications, Prolia’s duration in your system isn’t affected by your body weight or how well your kidneys work. Studies in patients ranging from 80 to over 300 pounds showed no meaningful differences in how the drug behaves. Similarly, patients with severe kidney impairment, including those on dialysis, cleared the drug at the same rate as everyone else. This means the six-month activity window and the post-discontinuation timeline apply broadly, regardless of your size or kidney health. No dose adjustment is needed for either factor.
What a Missed Dose Means
Because Prolia’s protective effect fades gradually over its six-month cycle, a delayed injection doesn’t immediately leave you unprotected the way missing a daily pill might. The FDA labeling says that if you miss a dose, you should get the injection as soon as possible, then restart the six-month schedule from that new date. There’s no need to double up or restart a loading phase.
That said, the longer you go past six months without a dose, the more bone breakdown resumes. If a missed dose stretches into several months, you’re entering the same rebound territory as someone who stopped treatment altogether. The practical takeaway: a few weeks late is unlikely to matter much, but months of delay starts to carry real consequences for your bone density.